136 related articles for article (PubMed ID: 8488764)
1. [Disodium pamidronate (APD) in the treatment of bone metastases].
Costa L; Moreira C; da Costa EB
Acta Med Port; 1993 Feb; 6(2):71-3. PubMed ID: 8488764
[TBL] [Abstract][Full Text] [Related]
2. Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.
Glover D; Lipton A; Keller A; Miller AA; Browning S; Fram RJ; George S; Zelenakas K; Macerata RS; Seaman JJ
Cancer; 1994 Dec; 74(11):2949-55. PubMed ID: 7525038
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
4. The role of disodium pamidronate in the management of bone pain due to malignancy.
Groff L; Zecca E; De Conno F; Brunelli C; Boffi R; Panzeri C; Cazzaniga M; Ripamonti C
Palliat Med; 2001 Jul; 15(4):297-307. PubMed ID: 12054147
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bone metastases from breast cancer and myeloma with pamidronate.
Thiébaud D; Leyvraz S; von Fliedner V; Perey L; Cornu P; Thiébaud S; Burckhardt P
Eur J Cancer; 1991; 27(1):37-41. PubMed ID: 1826438
[TBL] [Abstract][Full Text] [Related]
6. Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.
Morton AR; Cantrill JA; Pillai GV; McMahon A; Anderson DC; Howell A
BMJ; 1988 Sep; 297(6651):772-3. PubMed ID: 3142542
[No Abstract] [Full Text] [Related]
7. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
Hortobagyi GN; Theriault RL; Porter L; Blayney D; Lipton A; Sinoff C; Wheeler H; Simeone JF; Seaman J; Knight RD
N Engl J Med; 1996 Dec; 335(24):1785-91. PubMed ID: 8965890
[TBL] [Abstract][Full Text] [Related]
8. Disodium pamidronate in the treatment of bone metastases from breast cancer.
Colleoni M; Bochicchio AM; Nolè F; Bajetta E
Tumori; 1993 Oct; 79(5):340-2. PubMed ID: 8116078
[TBL] [Abstract][Full Text] [Related]
9. Pamidronate in incident pain due to bone metastases.
Mercadante S; Villari P; Ferrera P; Dabbene M
J Pain Symptom Manage; 2001 Aug; 22(2):630-1. PubMed ID: 11503631
[No Abstract] [Full Text] [Related]
10. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y
Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
Small EJ; Smith MR; Seaman JJ; Petrone S; Kowalski MO
J Clin Oncol; 2003 Dec; 21(23):4277-84. PubMed ID: 14581438
[TBL] [Abstract][Full Text] [Related]
13. [Pamidronate in the treatment of bone metastases from breast cancer].
Nagykálnai T; Landherr L; Zatkóné GP; Gyuricska A
Magy Onkol; 2002; 46(3):225-33. PubMed ID: 12368918
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.
Body JJ; Greipp P; Coleman RE; Facon T; Geurs F; Fermand JP; Harousseau JL; Lipton A; Mariette X; Williams CD; Nakanishi A; Holloway D; Martin SW; Dunstan CR; Bekker PJ
Cancer; 2003 Feb; 97(3 Suppl):887-92. PubMed ID: 12548591
[TBL] [Abstract][Full Text] [Related]
15. [Effects of pamidronate disodium (Bonin) combined with chemotherapy on bone pain in multiple myeloma].
Leng Y; Chen SL; Shi HZ
Space Med Med Eng (Beijing); 2002 Oct; 15(5):377-8. PubMed ID: 12449148
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.
Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein MA; Coleman RE; Reitsma DJ; Chen BL; Seaman JJ
Cancer; 2003 Oct; 98(8):1735-44. PubMed ID: 14534891
[TBL] [Abstract][Full Text] [Related]
17. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.
Bloomfield DJ
J Clin Oncol; 1998 Mar; 16(3):1218-25. PubMed ID: 9508210
[TBL] [Abstract][Full Text] [Related]
18. Treating bone metastases: sparing the patient needless pain.
McBride G
J Natl Cancer Inst; 1997 Mar; 89(6):418-9. PubMed ID: 9091642
[No Abstract] [Full Text] [Related]
19. Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study.
Hultborn R; Gundersen S; Rydén S; Holmberg E; Carstensen J; Wallgren UB; Kilany S
Acta Oncol; 1996; 35 Suppl 5():73-4. PubMed ID: 9142971
[No Abstract] [Full Text] [Related]
20. Pain relief and sclerosis of bone metastases in a patient with breast cancer treated with tamoxifen, radiotherapy and pamidronate disodium: which treatment helped?
Ripamonti C; Fulfaro F; Polastri D; De Conno F; Laffranchi A; Moliterni A
J Pain Symptom Manage; 1998 Aug; 16(2):73-6. PubMed ID: 9737095
[No Abstract] [Full Text] [Related]
[Next] [New Search]
